Adjunctive Glycine for Obsessive Compulsive Disorder

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether individuals with obsessive compulsive disorder who will take a preparation of the amino acid glycine in addition to their current treatment, may experience improvement in their symptoms.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nathan Kline Institute for Psychiatric Research
• Collaborator: Obsessive Compulsive Foundation
• Treatments: Glycine

Criteria

Inclusion Criteria:

• Diagnosis of OCD present for at least 1 year

• Male or female, age 18 to 65

• Stable medication regimen for 12 weeks prior to study entry

• at least moderately severe OC symptoms

Exclusion Criteria:

• Active substance use disorder within the last 6 months

• Comorbid schizophrenia, schizoaffective disorder, bipolar disorder, tic disorder, Tourette Disorder, schizotypal personality disorder

• Hoarding as the principal OCD symptom

• Insulin-dependent diabetes mellitus

• Pregnant or breastfeeding